Blue Fish families,

Blue Fish Pediatrics is happy to announce that we will offer Beyfortus (nirsevimab) to all infants birth to 8 months old. A very small percentage of patients ages 8-24 months with underlying medical conditions might also qualify for a dose of Beyfortus. To see if your child might qualify, please refer to the informational handout (link below). At this time, due to shipping constraints and newness of this medication, we will have a small stock in each office. Should your office not have available stock, we will contact you once the medication is available.

Beyfortus Informational Handout


Estimated to be approximately $500 out of pocket. As soon as nirsevimab is available, Blue Fish hopes to have it in stock. It will likely not be covered by insurances initially, but we will offer it for those families who qualify medically.

Parents can opt to pay for the treatment up front. (Insurances will be billed and reimbursement will be given should your insurance later pay.)